Pattern and cause of fractures in patients who abuse alcohol: What should we do about it?

Postgraduate Medical Journal

Volumn 89, Issue 1056, 2013, Pages 578-583

  Kelly, Kieran Nial ^a   Kelly, Clive ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; EPHRIN; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PLACEBO; SEX HORMONE; STRONTIUM; ZOLEDRONIC ACID;

ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; BODY MASS; BONE CELL; BONE DENSITY; COMORBIDITY; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG CONTRAINDICATION; FRACTURE; HIP FRACTURE; HUMAN; INCIDENCE; LIVER DISEASE; OSTEOPOROSIS; PANCREAS FUNCTION; PREVALENCE; REVIEW; RISK FACTOR; SPINE FRACTURE; TREATMENT CONTRAINDICATION;

EID: 84884410994     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2013-131990     Document Type: Review

References (66)

1. Strategy Unit Alcohol Harm Reduction Project-Interim Analytical Report. September 2003.
2. Pincock S. Binge drinking on rise in UK and elsewhere. Lancet 2003;362:1126-1127.
3. Bone and Joint Initiative USA. Condition Kit-Osteoporosis. http://www.usbjd.org/research/research_op.cfm?dirID=171 (accessed 13 August 2012).
4. Turner RT. Skeletal response to alcohol. Alcohol Clin Exp Res 2000;24:1693-1701.
5. Santori C, Ceccanti M, Diacinti D, et al. Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol. J Endocrinol Invest 2008;31:321-326.
6. Berg KM, Kunins HV, Jackson JL, etal. Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med 2008;121:406-418.
7. Chakkalakal DA. Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res 2005;29:2077-2090.
8. Nyquist F, Karlsson MK, Obrant KJ, et al. Osteopenia in alcoholics after tibia shaft fractures. Alcohol 1997;32:599-604.
9. Burge R, Worley D, Johansen A, et al. The cost of osteoporotic fractures in the UK: projections for 2000-2020. Journal of Medical Economics 2001;4:91-107.
10. Office for National Statistics (ONS). Living in Britain: results from the 1998 General Household Survey. London: The Stationery Office, 2000.
11. A Working Party of the Royal College of Physicians. ALCOHOL-can the NHS afford it? Recommendations for a coherent alcohol strategy for hospitals. February 2001.
12. Donath C, Gräßel E, Baier D, et al. Predictors of binge drinking in adolescents: ultimate and distal factors-a representative study. BMC Public Health 2012;12:263.
13. NHS Choices website. Binge drinking. http://www.nhs.uk/Livewell/alcohol/Pages/Bingedrinking.aspx
14. Ward R, Lallemand F, de Witte P. Biochemical and neurotransmitter changes implicated in alcohol-induced brain damage in chronic or 'binge drinking' alcohol abuse. Alcohol 2009;44:128-135.
15. Bikle DD, Genant HK, Cann C, et al. Bone disease in alcohol abuse. Ann Intern Med 1985;103:42-45.
16. Williams FMK, Cherkas LF, Spector TD. The effect of moderate alcohol consumption on bone mineral density: a study of female twins. Annals of the Rheumatic Diseases 2005;64:309-310.
17. Sampson HW. Alcohols harmful effects on bone. Alcohol Health Res World 1998;22:190-194.
18. Felson DT, Kiel DP, Anderson JJ, et al. Alcohol consumption and hip fractures: the Framingham Study. American Journal of Epidemiology 1988;128:1102-1110.
19. Díez-Ruiz A, García-Saura PL, García-Ruiz P, et al. Bone mineral density, bone turnover markers and cytokines in alcohol-induced cirrhosis. Alcohol 2010;45:427-430.
20. Kanis JA, Johansson H, Oden A, et al. Assessment of fracture risk. Eur J Radiol 2009;71:392-397.
21. Kanis JA, McCloskey EV, Johansson H, et al. Development and use of FRAX® in osteoporosis. Osteoporosis International 2010;21(Suppl 2):S407-S413.
22. Kanis JA, et al. http://www.shef.ac.uk/FRAX/tool.jsp (accessed 13 August 2012).
23. Kanis JA, Johansson H, Johnell O, et al. Alcohol intake as a risk factor for fracture. Osteoporosis Int 2005;16:737-742.
24. Feldman D, Wesley Pike J, Glorieux FH. Vitamin D (volume 1). Book Publishers Elsevier, 2004:1306-1307, Chapter 75.
25. González-Reimers E, Alvisa-Negrín J, Santolaria-Fernández F, et al. Vitamin D and nutritional status are related to bone fractures in alcoholics. Alcohol and Alcoholism 2011;46:148-155.
26. Kelly C, Bartholomew P, Reddy A. Serious effects of alcohol on Bone density and fracture incidence. Ann Rheum Dis 2012 (EULAR abstracts) Number 1013.
27. Report of a WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: World Health Organization, 1994, WHO Technical Report Series, No. 843.
28. Hoidrup S, Gronbaek M, Gottschau A, et al. Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 1999;149:993-1001.
29. Lawrence T, White C, Wenn R, et al. Total costs of hospital treatment for hip fractures. Injury 2005;36:88-91.
30. Stearns AT, Jaberoo MC, Ashraf R, et al. Displaced intracapsular hip fractures in the working age alcohol-abusing patient. Scott Med J 2009;54:16-20.
31. Naves Diaz M, O'Neill TW, Silman AJ. The influence of alcohol consumption on the risk of vertebral deformity. European Vertebral Osteoporosis Study Group. Osteoporosis Int 1997;7:65-72.
32. Israel Y, Orego H, Holt S, et al. Identification of alcohol abuse: thoracic fractures on routine chest X ray as indicators of alcoholism. Alcohol Clin Exp Res 1980;4:420-425.
33. Hemenway D, Colditz GA, Willett WC, et al. Fractures and lifestyle: effect of cigarette smoking, alcohol intake and relative weight on risk of hip and forearm fractures in middle aged women. Am J Public Health 1988;78:1554-1558.
34. Alvisa-Negrin J, Gonzalez-Reimers E, Santolaria-Fernandez F, et al. Osteopenia in alcoholics: effect of alcohol abstinence. Alcohol 2009;44:468-475.
35. Nyquist F, Ljunghall S, Berglund M, et al. Biochemical markers of bone metabolism after short and long time ethanol withdrawal in alcoholics. Bone 1996;19:51-54.
36. Diamond T, Stiel D, Lunzer M, et al. Ethanol reduces bone formation and may cause osteoporosis. Am J Med 1989;86:282-288.
37. Maurel DB, Boisseau N, Benhamou CL, et al. Alcohol and bone: review of dose effects and mechanisms. Osteoporosis International 2012;23:1-16.
38. Howe KS, Iwaniec UT, Turner RT. The effects of low dose parathyroid hormone on lumbar vertebrae in a rat model for chronic alcohol abuse. Osteoporosis International 2011;22:1175-1181.
39. Maran A, Zhang M, Spelsberg TC, et al. The dose-response effects of ethanol on the human fetal osteoblastic cell line. J Bone Miner Res 2001;16:270-276.
40. Cheng B, Zhao S, Luo J, et al. Expression of functional gap junctions and regulation by fluid flow in osteocyte-like MLO-Y4 cells. J Bone Miner Res 2001;16:249-259.
41. Maurel D, Jaffre C, Rochefort G, et al. Low bone accrual is associated with osteocyte apoptosis in alcohol-induced osteopenia. Bone 2011;49:543-552.
42. Cui Q, Wang Y, Mulhall K, et al. Alcohol-induced adipogenesis in a cloned cell line from bone marrow stroma. Bone Joint Surg Br 2006;88-B(Suppl II):303-308.
43. Maurel DB, Pallu S, Jaffré C, et al. Osteocyte apoptosis and lipid infiltration as mechanisms of alcohol-induced bone loss. Alcohol and Alcoholism 2012;47:413-422.
44. Gallego-Rojo FJ, Gonzales-Calvin JL, Oz-Torres MM, et al. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998;28:695-699.
45. Tsay J, Yang Z, Ross P, et al. Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 2010;116:2582-2589.
46. Ballinger A. Essentials of Kumar & Clark's clinical medicine. 5th edn. Saunders Elsevier, 2012:310-311.
47. Callaci JJ, Juknelis D, Patwardhan A, et al. Binge alcohol treatment increases vertebral bone loss following ovariectomy: compensation by intermittent parathyroid hormone. Alcohol Clin Exp Res 2006;30:665-672.
48. Raisz LG, Canalis EM, Dietrich JW, et al. Hormonal regulation of bone formation. Recent Prog Horm Res 1978:335-356.
49. Sacha T, Mann V, Mann H, et al. Fecal elastase 1 and vitamin D3 in patients with osteoporotic bone fractures. Europ J Med Res 2008;13:68-72.
50. Gavaler JS, Love K, Van Thiel D, et al. An international study of the relationships between alcohol consumption and post menopausal estradiol levels. Alcohol Suppl 1991;1:327-329.
51. Ruusa J, Bergman B, Sundell ML. Sex hormones during alcohol withdrawal: a longitudinal study of 29 male alcoholics during detoxification. Alcohol Alcohol 1997;32:591-597.
52. Nyquist F, Gärdsell P, Sernbo I, et al. Assessment of sex hormones and bone mineral density in relation to occurrence of fracture in men: a prospective population-based study. Bone 1998;22:147-151.
53. Sarkola T, Adlercreutz H, Heinonen S, et al. The role of the liver in the acute effect of alcohol on androgens in women. J Clin Endocrinol Metab 2001;86:1981-1985.
54. Wadhwa VK, Weston R, Mistry R, et al. Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values. BJU Int 2009;104:800-805.
55. Abrahamsen B, Brixen K. Mapping the prescription to fractures in men-a national analysis of prescription history and fracture risk. Osteoporos Int 2009;20:585-597.
56. Callaci J, Himes R, Lauing K, et al. Binge alcohol-induced bone damage is accompanied by differential expression of bone remodeling-related genes in rat vertebral bone. Calcif Tissue Int 2009;84:474-484.
57. Pierroz D, Rufo A, Bianchi E, et al. Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodelling in mice. J Bone Mineral Res 2009 # 19113915.
58. Hayashi M, Nakashima T, Taniguchi M, et al. Osteoprotection by semaphorin 3A. Nature 2012;485:69-74.
59. Malik P, Gasser RW, Moncayo R, et al. Markers of bone resorption and formation during abstinence in male alcoholic patients. Alcohol Clin Exp Res 2012;36:2059-2064.
60. Pettinati HM. Improving medication adherence in alcohol dependence. J Clin Psychiatry 2006;67(Suppl 14):23-29.
61. Black D, Delmas P, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809-1822.
62. Lyles K, Colo-Emeric C, Magaziner J, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007;357:1799-1809.
63. Maricic M. The role of zoledronic acid in the management of osteoporosis. Clin Rheumatol 2010;29:1079-1084.
64. Hamdy NA. Denosumab: RANKL inhibition in the management of bone loss. Drugs Today (Barc) 2008;44:7-21.
65. Adler RA, Gill RS. Clinical utility of denosumab for treatment of bone loss in men and women. Clin Interv Aging 2011;6:119-124.
66. Dore RK. Data from extension trials: denosumab and zoledronic acid. Curr Osteoporos Rep 2012;10:16-21.